Journal: International Journal of Molecular Sciences
Article Title: Detection of TRPM6 and TRPM7 Proteins in Normal and Diseased Cardiac Atrial Tissue and Isolated Cardiomyocytes
doi: 10.3390/ijms232314860
Figure Lengend Snippet: Effect of cardiac disease conditions on TRPM6 and TRPM7: ( A – C ) TRPM fluorescence intensity levels in RA cells ( A ) or tissues ( B , C ). Fluorescence intensity levels of TRPM6 (unfilled) and TRPM7 (filled) channels in isolated cardiomyocytes of the human heart, grouped according to the heart rhythm (SR vs. AF, ( A )) or according to the absence or presence of ischemic heart disease (non-IHD vs. IHD, ( B )). Fluorescence intensity levels of TRPM6 (unfilled) and TRPM7 (filled) channels in histological slices grouped according to the heart rhythm (SR vs. AF, ( C )); ( D ) TRPM7 and TRPM6 protein levels in human heart tissue homogenates grouped according to the heart rhythm and the presence of ischemic disease. Mean data of immunofluorescence provided in arbitrary units (a.u) for TRPM6 and TRPM7: * and ** p < 0.05 AF vs. SR, respectively, in isolated cells; # and ## p < 0.01 IHD vs. non-IHD, respectively, in tissue sections; $ and $$ p < 0.01 AF vs. SR, respectively, in tissue sections, and mean data of TRPM6 and TRPM7 protein concentrations in pg/mL, † and †† p < 0.05 AF vs. SR, ‡ and ‡‡ p < 0.05 IHD vs. SR (non-IHD), respectively.
Article Snippet: The blocking peptide for anti-TRPM7 antibody (#BLP-CC047) and the blocking peptide for anti-TRPM6 (#BPL-CC046) was created by Alomone Labs for the antibody TRPM6 or TRPM7.
Techniques: Fluorescence, Isolation, Immunofluorescence